Document is current
Any future updates will be listed below
-
Authors
Lennox, Belinda R.
- License Information
-
More Information
Article History
First Online: 2 March 2022
Competing interests
: B.R.L. is running a trial of immunotherapy in antibody-positive psychosis, SINAPPS2 (), and has received research funding for related research from Janssen.
